Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation

Biochemical and Biophysical Research Communications

Volumn 374, Issue 2, 2008, Pages 282-287

  Wen, Yanting ^a   Ouyang, Jian ^a   Yang, Rong ^b   Chen, Junhao ^b   Liu, Yong ^b   Zhou, Xiaojun ^c   Burt, Richard K ^d  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c JINLING HOSPITAL   (China)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

CD4+CD25+FoxP3+ regulatory T cells; Immunologic tolerance; Syngeneic bone marrow transplantation; Type 1 diabetes

Indexed keywords

INSULIN; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL REGENERATION; CONTROLLED STUDY; DONOR; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; ISOGRAFT; MALE; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECIPIENT; RECURRENT DISEASE; REGULATORY T LYMPHOCYTE; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN CELL; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD4; BLOOD GLUCOSE; BONE MARROW TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; FORKHEAD TRANSCRIPTION FACTORS; INSULIN; MALE; MICE; MICE, INBRED C57BL; PANCREAS; REGENERATION; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME;

MUS;

EID: 48549099493     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.016     Document Type: Article

References (26)

1. Mandrup-Poulsen T. Beta cell death and protection. Ann. NY Acad. Sci. 1005 (2003) 32-42
2. Elkin G., Prigozhina T.B., and Slavin S. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. Exp. Hematol. 32 (2004) 579-584
3. Kang E.M., Zickler P.P., Burns S., Langemeijer S.M., Brenner S., Phang O.A., Patterson N., Harlan D., and Tisdale J.F. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp. Hematol. 33 (2005) 699-705
4. Like A., and Rossini A. Streptozocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193 (1976) 415-417
5. Muller A., Schott-Ohly P., Dohle C., and Gleichmann H. Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 205 (2002) 35-50
6. Burt R.K., Slavin S., Burns W.H., and Marmont A.M. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99 (2002) 768-784
7. Herrmann M.M., Gaertner S., Stadelmann C., van den Brandt J., Boscke R., Budach W., Reichardt H.M., and Weissert R. Tolerance induction by bone marrow transplantation in a multiple sclerosis model. Blood 106 (2005) 1875-1883
8. Voltarelli J.C., Couri C.E., Stracieri A.B., Oliveira M.C., Moraes D.A., Pieroni F., Coutinho M., Malmegrim K.C., Foss-Freitas M.C., Simoes B.P., Foss M.C., Squiers E., and Burt R.K. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 297 (2007) 1568-1576
9. Burt R.K., Loh Y., Pearce W., Beohar N., Barr W.G., Craig R., Wen Y., Rapp J.A., and Kessler J. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299 (2008) 925-936
10. Beilhack G.F., Landa R.R., Masek M.A., and Shizuru J.A. Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants. Diabetes 54 (2005) 1770-1779
11. Nikolic B., Takeuchi Y., Leykin I., Fudaba Y., Smith R.N., and Sykes M. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity. Diabetes 53 (2004) 376-383
12. Verda L., Kim D.A., Ikehara S., Statkute L., Bronesky D., Petrenko Y., Oyama Y., He X., Link C., Vahanian N.N., and Burt R.K. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice. Stem Cells 26 (2008) 381-386
13. Brodnicki T.C., Quirk F., and Morahan G. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes 52 (2003) 218-222
14. Metcalfe K.A., Hitman G.A., Rowe R.E., Hawa M., Huang X., Stewart T., and Leslie R.D. Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care 24 (2001) 838-842
15. Burt R.K., Oyama Y., Traynor A., and Kenyon N.S. Hematopoietic stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis. Autoimmun. Rev. 1 (2002) 133-138
16. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., and Bluestone J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
17. Battaglia M., Stabilini A., Draghici E., Migliavacca B., Gregori S., Bonifacio E., and Roncarolo M.G. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 55 (2006) 1571-1580
18. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2 (2002) 389-400
19. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22 (2004) 531-562
20. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6 (2005) 345-352
21. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
22. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
23. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
24. Hori S., and Sakaguchi S. Foxp3: a critical regulator of the development and function of regulatory T cells. Microbes Infect. 6 (2004) 745-751
25. de Kleer I., Vastert B., Klein M., Teklenburg G., Arkesteijn G., Yung G.P., Albani S., Kuis W., Wulffraat N., and Prakken B. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood 107 (2006) 1696-1702
26. Roord S.T., de Jager W., Boon L., Wulffraat N., Martens A., Prakken B., and van Wijk F. Autologous bone marrow transplantation in autoimmune arthritis restores immune homeostasis through CD4+CD25+FOXP3+ regulatory T cells. Blood (2008)